Published Date: 16/11/2010
Category: Consumer Health & Nutrition
The advanced wound care sector is feeling the pressure... In terms of the overall market, growth in the advanced wound care sector slowed significantly between 2008 and 2009. This was mainly the result of intensifying competition and lower healthcare spending as governments attempt to reduce deficits following the global economic downturn. Both of these factors have led to weaker pricing. Currently, there is much uncertainty as to when market conditions will improve, or how planned changes to healthcare budgets will impact the advanced wound care market.   Â
Advanced Oxygen Therapy, Arobella Medical, BioElectronics, Biofiscia, Boehringer Techologies, Celleration, Genadyne Technologies, Gettinge, Health Care, Prospera, Innovative Therapeutics, Kalypto Medical, Kinestic Concepts, Medela Invta, MIsontix, Molnlycke, NanoVibrontx, Regenesis Biomedical, SanoMed, Soring, Sanuwave, Smith & Nephew, SynapseTalley Group, Tissue Regeneration Technologies,Vibrant, Vomart
This new analysis forecasts market growth of around 4% for both 2010 and 2011. Although pricing is likely to remain weak at least in the short term, growth will come from the increasing numbers of chronic wounds and the introduction of new products.The biologics products market is characterised by more innovation than any other sector, although this is the smallest segment of the industry and barriers to market entry are the highest. While Espicom predicts solid market growth for biologic products to 2015, this will be dependent on companies having the funds to bring products to market and successfully completing their clinical development programmes. Â
What this report will give you